CSPC Innovation Pharmaceutical Co Ltd Class A - Asset Resilience Ratio

Latest as of March 2026: 5.64%

CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has an Asset Resilience Ratio of 5.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CSPC Innovation Pharmaceutical Co Ltd Cl (300765) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥350.30 Million
≈ $51.26 Million USD Cash + Short-term Investments

Total Assets

CN¥6.21 Billion
≈ $908.72 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is CSPC Innovation Pharmaceutical Co Ltd Cl's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down CSPC Innovation Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 300765 current and long-term liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥350.30 Million 5.64%
Total Liquid Assets CN¥350.30 Million 5.64%

Asset Resilience Insights

  • Limited Liquidity: CSPC Innovation Pharmaceutical Co Ltd Class A maintains only 5.64% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

CSPC Innovation Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio

Compare CSPC Innovation Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
B&G Foods Inc
NYSE:BGS
Packaged Foods 1.99%
Saputo Inc
TO:SAP
Packaged Foods 3.36%
Lotus Bakeries
BR:LOTB
Packaged Foods 2.28%
COFCO Tunhe Sugar Co Ltd
SHG:600737
Packaged Foods 0.08%
Nongshim
KO:004370
Packaged Foods 25.51%
Grupo Bimbo S.A.B. de C.V
MX:BIMBOA
Packaged Foods 0.15%
Avanti Feeds Limited
NSE:AVANTIFEED
Packaged Foods 65.24%
Juewei Food Co Ltd
SHG:603517
Packaged Foods 3.18%

Annual Asset Resilience Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2019–2025)

The table below shows the annual Asset Resilience Ratio data for CSPC Innovation Pharmaceutical Co Ltd Class A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 6.14% CN¥385.39 Million
≈ $56.39 Million
CN¥6.28 Billion
≈ $918.42 Million
-1.67pp
2024-12-31 7.81% CN¥470.09 Million
≈ $68.79 Million
CN¥6.02 Billion
≈ $881.22 Million
-3.25pp
2021-12-31 11.06% CN¥413.59 Million
≈ $60.52 Million
CN¥3.74 Billion
≈ $547.46 Million
+0.17pp
2020-12-31 10.89% CN¥321.94 Million
≈ $47.11 Million
CN¥2.96 Billion
≈ $432.64 Million
-22.77pp
2019-12-31 33.66% CN¥960.09 Million
≈ $140.49 Million
CN¥2.85 Billion
≈ $417.39 Million
--
pp = percentage points

About CSPC Innovation Pharmaceutical Co Ltd Class A

SHE:300765 China Packaged Foods
Market Cap
$9.02 Billion
CN¥61.63 Billion CNY
Market Cap Rank
#2427 Global
#280 in China
Share Price
CN¥43.88
Change (1 day)
+1.41%
52-Week Range
CN¥23.23 - CN¥51.78
All Time High
CN¥189977.21
About

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food product… Read more